Angelini Pharma and Lumira Ventures launch the Angelini Lumira Biosciences Fund (ALBF) Angelini Pharma and Lumira Ventures launch the Angelini Lumira Biosciences Fund (ALBF) - Angelini Pharma will invest US$35 million and be the sole investor in this innovative fund - ALBF will invest...

Angelini Pharma and Lumira Ventures launch the Angelini Lumira Biosciences Fund (ALBF) Angelini Pharma and Lumira Ventures launch the Angelini Lumira Biosciences Fund (ALBF) - Angelini Pharma will invest US$35 million and be the sole investor in this innovative fund - ALBF will invest...

Notch Therapeutics – a new company with a revolutionary allogeneic ("off the shelf") T cell technology Toronto, ON, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Notch Therapeutics, a company in the emerging field of gene-modified T cell therapy, has been created to commercialize a revolutionary technology that...